Insys Therapeutics names current CFO Andrew Long as company’s new CEO
April 17, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insys Therapeutics, appointment, pharma
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Imperial College London researchers developing tech to monitor dementia patients at home
April 17, 2019Research and Development dementia, imperial college london, pharma
Researchers at Imperial College London are hard at work developing technology to aid the lives of dementia patients in their …
MS Pharma ink deal for acquisition of Genepharm
April 17, 2019Research and Development
Jordanian firm MS Pharma has entered into an agreement to acquire 100% of the outstanding shares of Greek company Genepharm. …
NICE recommends Akcea’s Tegsedi for rare, life-threatening progressive disease
April 17, 2019Research and Development, Sales and Marketing Akcea, NHS, NICE, Tegsedi, UK
Akcea Therapeutics has shared the news that Tegsedi (inotersen), its antisense oligonucleotide (ASO) inhibitor of human transthyretin (TTR) production, has …
China introduces new laws to ensure steady supply of drugs
April 17, 2019Research and Development China, National Health Commission, laws, markets, pharma, regulation
China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure …
GSK to make redundancies at plant in Stevenage
April 17, 2019Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage
GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …
Use of Genzyme’s MS drug Lemtrada restricted under ongoing EMA safety review
April 16, 2019Manufacturing and Production, Sales and Marketing EMA, Genzyme, Lemtrada, multiple sclerosis, pharma
The EMA has launched a review into Genzyme’s multiple sclerosis drug Lemtrada (alemtuzumab) after reports emerged of treatment-related safety issues …
Genentech employee awarded $250,000 over racial discrimination case
April 16, 2019Manufacturing and Production Genentech, discrimination, pharma, racial discrimination, racism
A US jury has awarded a former Genentech employee nearly $250,000 after the black worker was fired from the firm …
Insys Therapeutics names current CFO Andrew Long as company’s new CEO
April 16, 2019Manufacturing and Production CEO, Insys Therapeutics, Subsys, appointments, cfo, pharma
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Janssen’s Invokana combo smashes primary and secondary endpoints in chronic kidney disease
April 16, 2019Manufacturing and Production, Research and Development Janssen, cardiovascular, chronic kidney disease, diabetes, invokana, pharma
Janssen has unveiled promising new Phase 3 for its sodium-glucose transport (SGLT) protein-2 inhibitor Invokana (canagliflozin), showing that the therapy …
Half of patients have sub-optimal response to statins, research shows
April 16, 2019Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins
Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …
Pfizer unveils new Phase 2 data on 20-valent pneumococcal conjugate vaccine
April 15, 2019Research and Development, Sales and Marketing Pfizer, Streptococcus pneumoniae, Vaccine, pharma
Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC), detailing the …
Bowel cancers adjust themselves to hide from immunotherapies
April 15, 2019Sales and Marketing CEA, Cancer, bowel cancer, immunotherapy, oncology, tumour
Bowel cancers can avoid being caught by immunotherapy by ‘switching off’ a molecule on the surface of cells that is …
Doctors treat porphyria using innovative gene silencing drug
April 15, 2019Sales and Marketing RNA, gene silencing, genetics, givosiran, health, porphyria
Doctors have successfully treated porphyria using an innovative ‘gene-silencing’ drug. Speaking to the BBC, Professor David Rees, from King’s College …
Janssen’s Balversa becomes first FDA-approved FGFR kinase inhibitor for advanced bladder cancer
April 15, 2019Sales and Marketing Balversa, Cancer, FDA, Janssen, bladder cancer, pharma
Janssen’s Balversa (erdafitinib) has become the first FDA-approved fibroblast growth factor receptor (FGFR) kinase inhibitor after the US agency authorised …
Medical cannabis: A green light for patients in need?
April 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma
Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …
Clovis Oncology discontinue phase 2 bladder cancer trial
April 15, 2019Sales and Marketing Cancer, Clovis Oncology, US, bladder cancer, metastatic bladder cancer
Colorado-based pharma firm Clovis Oncology has said in a filing to the US Securities and Exchange Commission that it is …
Bayer VP elected to two of the firm’s executive committees
April 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, appointment
Dr Monika Lessl has been appointed to Bayer Foundations’ executive committee, selected by the German pharmaceutical firm’s Board of Management …
Daiichi Sankyo name current COO Sunao Manabe as firm’s new CEO
April 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Daiichi Sankyo have said Sunao Manabe, the company’s current COO will take over from George Nakayama as the firm’s new …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
